Endoluminal Suturing Devices Market Analysis 2026

Factors Affecting Endoluminal Suturing Devices Market Growth

• The rising prevalence of chronic diseases

The rising prevalence of chronic diseases such as obesity, gastrointestinal cancers, inflammatory bowel disease, and other digestive diseases are major factors driving the growth of the market. Globally, obesity has reached epidemic levels; at least 2.8 million individuals each year pass away as a result of being overweight or obese. The US has previously been criticized for having the highest rate of obesity. According to the Centers for Disease Control and Prevention, the US obesity prevalence was 41.9% in 2017–March 2020, which rose from 30.5% to 41.9% from 1999–2000 through 2017–March 2020. The prevalence of severe obesity rose from 4.7% to 9.2% throughout the same period. Moreover, according to NCBI, the inflammatory bowel disease prevalence was 321.2 per 100,000 people in 2021 and has increased at a rate of more than 46% when compared to 2006 (200 per 100,000 people). These chronic diseases often require surgical interventions, and endoluminal suturing devices offer a less invasive option for patients. These devices have the ability to provide effective suturing with minimal trauma and faster recovery times is increasing their popularity among both patients and healthcare professionals. Therefore, the increase in the prevalence of these diseases is fuelling the growth of the endoluminal suturing devices market.

• The increasing preference for minimally invasive weight loss surgeries is accelerating the endoluminal suturing devices market

Minimally invasive weight loss surgeries are becoming increasingly popular due to their lower risk of complications, shorter hospital stays, and faster recovery times compared to traditional open surgeries. These procedures are designed to help patients lose weight by reducing the size of their stomachs, which limits their food intake. Endoluminal suturing devices are used in these procedures to suture the stomach tissue, creating a smaller pouch that can hold less food. The use of endoluminal suturing devices in these procedures provides several advantages, such as reduced trauma to the surrounding tissue, decreased risk of infection, and faster healing times. These factors fuel the demand for minimally invasive weight loss surgeries such as gastric bypass and sleeve gastrectomy, which is driving the growth of the endoluminal suturing devices market.

The high cost of procedures may hamper the growth of the endoluminal suturing devices market

• High cost of procedures

The high cost of procedures is one of the factors that can hamper the growth of the endoluminal suturing devices market. Although endoluminal suturing devices offer several advantages over traditional surgical techniques, they can be expensive to use, and the cost of the procedure may be a limiting factor for some patients and healthcare providers. The cost of endoluminal suturing devices is high due to the cost of the device itself, the expenses of training healthcare professionals to use the device, and the cost of maintenance and repair. These expenses can add up, making endoluminal suturing procedures more expensive than traditional surgical techniques.

Current Trends on Endoluminal Suturing Devices

• Technological advancements in endoluminal devices are fuelling the endoluminal suturing devices market

Technological advancements such as the emergence of robotic-assisted endoluminal suturing devices, the integration of artificial intelligence into endoluminal devices, miniaturization, and the integration of wireless communication technology into endoluminal devices have enabled real-time data transmission between the device and the surgeon. These technological advancements have greatly improved the accuracy, efficiency, and effectiveness of surgical procedures, resulting in better outcomes for patients. This integration of new technologies is projected to support the growth of the endoluminal suturing devices market during the forecast period.

Impact of the COVID-19 Pandemic on the Endoluminal Suturing Devices Market:

The sudden outbreak of the COVID-19 pandemic has had a significant impact on the healthcare industry, including the endoluminal suturing devices market. The pandemic caused disruptions in the global supply chain, which has impacted the production and distribution of endoluminal suturing devices. The lockdowns and travel restrictions imposed by many countries have made it difficult to transport medical devices, and the shortage of raw materials has caused delays in manufacturing. 
However, the COVID-19 pandemic has affected people’s health globally. The increased prevalence of obesity has been observed in several countries across the world during the pandemic. According to the survey conducted by the American Psychological Association (APA), in March 2021, around 42% of Americans gained weight, and obesity rates have risen in the U.S. during the pandemic. Thus, the increasing prevalence of obesity will drive the demand for bariatric surgery, which in turn is projected to fuel the growth of the endoluminal suturing devices market during the forecast period. Furthermore, the pandemic has highlighted the importance of minimally invasive surgical techniques, which could potentially drive the adoption of endoluminal suturing devices in the future.

Our study will explain complete manufacturing process along with major raw materials required to manufacture end-product. This report helps to make effective decisions determining product position and will assist you to understand opportunities and threats around the globe.

The Global Endoluminal Suturing Devices Market is witnessing significant growth in the near future.

In 2023, the segment accounted for noticeable share of global Endoluminal Suturing Devices Market and is projected to experience significant growth in the near future.

The Bariatric Surgery segment is expected to expand at the significant CAGR retaining position throughout the forecast period.

Some of the key companies Apollo Endosurgery Inc. , Johnson & Johnson and others are focusing on its strategy building model to strengthen its product portfolio and expand its business in the global market.

Frequently Asked Questions (FAQs)